Bibliography
- Rangasamy SB , SoderstromK, BakayRA, KordowerJH. Neurotrophic factor therapy for Parkinson‘s disease. Prog. Brain Res.184, 237–264 (2010).
Patent
- Cordis Corporation: US7927529 (2011).
Websites
- Iroko Pharmaceuticals acquires iCeutica to bolster capabilities in novel low-dose NSAIDs www.iroko.com/news/iroko-pharmaceuticals-acquires-iceutica-bolster-capabilities-novel-low-dose-nsaids (Accessed on 16 May 2011)
- iCeutica http://iceutica.com/ (Accessed on 16 May 2011)
- iCeutica announces Sale to Partner Iroko; 10X uplift on original value http://iceutica.com/news (Accessed on 16 May 2011)
- Teva to acquire Cephalon in $6.8 billion transaction www.tevapharm.com/pr/2011/pr_1008.asp (Accessed on 16 May 2011)
- Teva Pharmaceutical Industries Ltd (TEVA.TA) (TEVA.O) struck a deal to acquire US specialty drugmaker Cephalon, Inc. (CEPH.O) for nearly $7 billion, topping an unsolicited bid by Canada‘s Valeant Pharmaceuticals International, Inc. Article in Reuters website on 2 May 2011 by Lewis Krauskopf www.reuters.com/article/2011/05/02/us-teva-cephalon-idUSTRE74133720110502 (Accessed on 16 May 2011)
- Cephalon‘s board of directors rejects Valeant Pharmaceuticals‘ unsolicited proposal www.cephalon.com/media/news-releases.html (Accessed on 16 May 2011)
- Alkermes to merge with Elan Drug Technologies to create Alkermes plc http://investor.alkermes.com/phoenix.zhtml?c=92211&p=RssLanding&cat=news&id=1561074 (Accessed on 16 May 2011)
- Precision NanoSystems and Alnylam form new delivery collaboration http://phx.corporate-ir.net/phoenix.zhtml?c=148005&p=irol-newsArticle&ID=1551836&highlight= (Accessed on 16 May 2011)
- Alnylam Pharmaceuticals, Inc. www.alnylam.com/index.php (Accessed on 29 May 2011)
- AlCana Technologies, The University of British Columbia, and Alnylam extend delivery research collaboration http://phx.corporate-ir.net/phoenix.zhtml?c=148005&p=irol-newsArticle&ID=1547664&highlight= (Accessed on 29 May 2011)
- NanoBio® announces development of nasal vaccine for the prevention of urinary tract infections in collaboration with the University of Michigan www.nanobio.com/NanoBio_Urinary_Tract_Infections_Vaccine.html (Accessed on 20 May 2011)
- NanoBio®www.nanobio.com (Accessed on 25 May 2011)
- Gilead and MicroDose Therapeutx announce license and collaboration agreement to develop MDT-637 for treatment of respiratory syncytial virus http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-newsArticle&ID=1552620&highlight= (Accessed on 20 May 2011)
- Section on MicroDose dry powder inhaler on the MicroDose Therapeutx http://mdtx.com/delivery-platforms/dry-powder-inhaler (Accessed on 25 May 2011)
- MonoSol Rx and KemPharm to develop novel PharmFilm® product for ADHD. Press release on PR Newswire www.prnewswire.com/news-releases/monosol-rx-and-kempharm-to-develop-novel-pharmfilm-product-for-adhd-120594304.html (Accessed on 19 May 2011)
- KemPharm www.kempharm.com (Accessed on 19 May 2011)
- MonoSol Rx www.monosolrx.com (Accessed on 19 May 2011)
- Lilly and Medtronic announce drug-device collaboration for Parkinson‘s disease wwwp.medtronic.com/Newsroom/NewsReleaseDetails.do?itemId=1303822510611&lang=en_US (Accessed on 19 May 2011)
- Compass biotechnologies (COBI:OB) announces memorandum of understanding with Arecor Ltd., of Cambridge UK to develop heat stable hepatitis B vaccine. Press release on PR Newswire www.prnewswire.com/news-releases/compass-biotechnologies-cobiob-announces-memorandum-of-understanding-with-arecor-ltd-of-cambridge-uk-to-develop-heat-stable-hepatitis-b-vaccine-120687839.html (Accessed on 19 May 2011)
- Arestat™ technology section on the Arecor Ltd website www.arecor.com/arestat-tc.aspx#protonexchange (Accessed on 19 May 2011)
- ViroPharma and Halozyme announce collaboration for combination of recombinant human hyaluronidase enzyme (rHuPH20) technology with C1 esterase inhibitor http://ir.viropharma.com/releasedetail.cfm?releaseid=576169 (Accessed on 19 May 2011)
- Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human]) http://phx.corporate-ir.net/phoenix.zhtml?c=175436&p=irol-newsArticle&ID=1562425&highlight= (Accessed on 19 May 2011)
- FDA Licenses Sanofi Pasteur‘s new influenza vaccine delivered by intradermal microinjection http://en.sanofi.com/binaries/20110509_FLUZONE_en_tcm28–32635.pdf (Accessed on 20 May 2011)
- FDA issues complete response letter for Aricept® patch (donepezil transdermal system) www.eisai.com/news/news201135.html (Accessed on 20 May 2011)
- Eisai Aricept patch rejected in USA, Halaven approved in Japan. Article by Kevin Grogan in PharmaTimes www.pharmatimes.com/ARTICLE/11–04–26/Eisai_Aricept_patch_rejected_in_USA_Halaven_approved_in_Japan.aspx (Accessed on 20 May 2011)
- pSivida announces new safety and efficacy data from Phase 3 study of Iluvien® in diabetic macular edema http://phx.corporate-ir.net/phoenix.zhtml?c=168274&p=irol-newsArticle&ID=1558615&highlight= (Accessed on 25 May 2011)
- pSivida announces resubmission of new drug application for Iluvien®http://phx.corporate-ir.net/phoenix.zhtml?c=168274&p=irol-newsArticle&ID=1563540&highlight= (Accessed on 25 May 2011)
- Diamyd medical: Diamyd reports initial results from European Phase III trial in patients newly diagnosed with Type 1 diabetes www.diamyd.com/docs/pressClip.aspx?section=investor&ClipID=570262 (Accessed on 25 May 2011)
- Section on endovascular products on Cordis Corporation‘s website www.cordis.com/products/precise-pro-rx-carotid-stent-system (Accessed on 25 May 2011)
- NeurogesX receives notice of allowance for patent covering NGX-1998 capsaicin topical liquid http://ngsx.client.shareholder.com/releasedetail.cfm?ReleaseID=572771 (Accessed on 25 May 2011)
- Qutenza www.qutenza.com (Accessed on 29 May 2011)
- AcelRx European patent covering its NanoTab® sublingual delivery for acute and breakthrough pain pipeline products emerges from opposition period http://news.acelrx.com/phoenix.zhtml?c=241441&p=irol-acelrxnewsArticle&ID=1561777&highlight= (Accessed on 25 May 2011)